Research with Impact

• Overview
• Promotional Effectiveness Measurement
• BrandImpact^™
• Oncology
• SalesImpact^™
• Consulting Analytics
• AlphaDetail Custom Research

Oncology

Within the US biopharmaceutical marketplace, there are currently more products in development within oncology therapeutic classes than any other disease area.  Given this intense focus many pharmaceutical companies are increasing their resources and specialization within this arena.  ImpactRx has the experience and capabilities to be an essential partner to your company within the unique and dynamic oncology market. 

We do this by identifying valuable market opportunities and evaluating competitor behavior in the growing oncology field. In addition to tracking sales representative promotion efforts, we follow and track the physician’s diagnosis and treatment behavior to provide distinct insight into competitive activity and overall impact of promotion on Oncologist treatment behavior.  

BrandImpact™ Oncology is the industry’s only source of Oncology promotion and treatment data, collected continuously in real-time from a longitudinal panel of high-value, nationally representative, iPhone/iPad-connected Oncologists. These solution suites provide clients with:

• > Oncology specific benchmarks and analogs, based on 5+ years of historical data across all promoted products and their approved indications, including over 25 product and/or new tumor indication launches
• > Access to more than 30,000 sales representative details and 400,000 patient visits annually within the oncology marketplace
• > Treatment behaviors by indication along with supportive care use, with complete competitive context by brand/regimen choice within line of therapy
• > Treatment data that includes specific diagnosis related elements such as biomarkers and diagnostic tests (i.e., Her2, KRAS, 17p deletion)
• > Closer view of the cause-and-effect link between Oncologist treatment decisions and influencing metrics, such as rep performance and quality, as well as comparison of selling activity by indication
• > Trends among Oncologist segments to categorize best practices within various subgroups of specialization or practice dynamics